ZNS MITTEL, VERFAHREN ZU SEINER HERSTELLUNG UND DIESES ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN

The agent is the compound 3-ä2-Ä4-(6-fluoro-benzoÄdÜisoxazol-3-il)-3,6-dihydro-2H-pyridin-1-ilÜ- ethylü-2-methyl-6,7,8,9-tetrahydropyridoÄ1,2-aÜpyrimidin-4-one having the formula (I) and pharmaceutically acceptable salts thereof; the process is based on the reduction of a selected pyridin salt by me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CASTILLO NIETO, JUAN CARLOS DEL, E-08027 BARCELONA, ES, MARQUILLAS OLONDRIZ, FRANCISCO, E-08034 BARCELONA, ES, CALDERO GES, JOSE MARIA, E-08034 BARCELONA, ES, HUGUET, CLOTET, JOAN, E-08970 SANT JOAN DESPI, ES, BOSCH ROVIRA, ANNA, E-08017 BARCELONA, ES, ROCA ACIN, JOAN, E-08006 BARCELONA, ES, DALMASES BARJOAN, PERE, E-08980 SANT FELIU DE LLOBREGAT, ES
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The agent is the compound 3-ä2-Ä4-(6-fluoro-benzoÄdÜisoxazol-3-il)-3,6-dihydro-2H-pyridin-1-ilÜ- ethylü-2-methyl-6,7,8,9-tetrahydropyridoÄ1,2-aÜpyrimidin-4-one having the formula (I) and pharmaceutically acceptable salts thereof; the process is based on the reduction of a selected pyridin salt by means of a metal borohydride; its preferred application is as an antipsychotic agent.